Similar to anti-CTLA-4, anti-PD-L1 as a monotreatment induced a tumor growth delay without inducing cures (Fig. 6d), but resulted in CR in 50% of animals when combined with AU-011 (Fig. 6d). Here, CTLA4 is linked to neoplasm.